Profund Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $269K | Buy |
11,892
+19
| +0.2% | +$422 | 0.01% | 822 |
|
|
2025
Q4 | $307K | Buy |
11,873
+1,347
| +13% | +$32K | 0.01% | 853 |
|
|
2025
Q3 | $271K | Sell |
10,526
-1,718
| -14% | -$42.2K | 0.01% | 794 |
|
|
2025
Q2 | $293K | Sell |
12,244
-1,621
| -12% | -$40.9K | 0.01% | 708 |
|
|
2025
Q1 | $345K | Buy |
13,865
+2,139
| +18% | +$51.2K | 0.02% | 613 |
|
|
2024
Q4 | $221K | Sell |
11,726
-5,985
| -34% | -$105K | 0.01% | 957 |
|
|
2024
Q3 | $267K | Buy |
17,711
+7,160
| +68% | +$122K | 0.01% | 869 |
|
|
2024
Q2 | $302K | Buy |
10,551
+2,190
| +26% | +$62.3K | 0.01% | 720 |
|
|
2024
Q1 | $244K | Sell |
8,361
-2,645
| -24% | -$81.3K | 0.01% | 965 |
|
|
2023
Q4 | $371K | Sell |
11,006
-1,252
| -10% | -$36.6K | 0.02% | 674 |
|
|
2023
Q3 | $376K | Buy |
12,258
+2,415
| +25% | +$87K | 0.02% | 555 |
|
|
2023
Q2 | $394K | Sell |
9,843
-524
| -5% | -$21.7K | 0.02% | 584 |
|
|
2023
Q1 | $423K | Buy |
10,367
+4,363
| +73% | +$174K | 0.03% | 556 |
|
|
2022
Q4 | $232K | Sell |
6,004
-296
| -5% | -$14.4K | 0.02% | 813 |
|
|
2022
Q3 | $335K | Sell |
6,300
-347
| -5% | -$19.3K | 0.02% | 534 |
|
|
2022
Q2 | $388K | Sell |
6,647
-717
| -10% | -$47K | 0.02% | 510 |
|
|
2022
Q1 | $562K | Buy |
7,364
+140
| +2% | +$9.33K | 0.02% | 496 |
|
|
2021
Q4 | $435K | Buy |
7,224
+128
| +2% | +$7.06K | 0.01% | 708 |
|
|
2021
Q3 | $397K | Sell |
7,096
-922
| -11% | -$53.1K | 0.01% | 751 |
|
|
2021
Q2 | $487K | Buy |
8,018
+548
| +7% | +$34.7K | 0.02% | 689 |
|
|
2021
Q1 | $524K | Sell |
7,470
-616
| -8% | -$44K | 0.02% | 569 |
|
|
2020
Q4 | $484K | Buy |
8,086
+1,799
| +29% | +$105K | 0.02% | 554 |
|
|
2020
Q3 | $378K | Sell |
6,287
-391
| -6% | -$22.7K | 0.02% | 555 |
|
|
2020
Q2 | $350K | Buy |
+6,678
| New | +$279K | 0.02% | 515 |
|
|
2020
Q1 | – | Sell |
-7,279
| Closed | -$330K | – | 1059 |
|
|
2019
Q4 | $330K | Sell |
7,279
-184
| -2% | -$7.82K | 0.01% | 861 |
|
|
2019
Q3 | $284K | Buy |
+7,463
| New | +$298K | 0.01% | 952 |
|
|
2019
Q1 | – | Sell |
-6,187
| Closed | -$266K | – | 1235 |
|
|
2018
Q4 | $266K | Sell |
6,187
-2,773
| -31% | -$129K | 0.02% | 844 |
|
|
2018
Q3 | $440K | Buy |
+8,960
| New | +$387K | 0.02% | 916 |
|
|
2016
Q1 | – | Sell |
-3,799
| Closed | -$292K | – | 1474 |
|
|
2015
Q4 | $292K | Buy |
+3,799
| New | +$215K | 0.01% | 956 |
|
|
2015
Q3 | – | Sell |
-5,166
| Closed | -$365K | – | 1325 |
|
|
2015
Q2 | $365K | Buy |
5,166
+114
| +2% | +$8.98K | 0.02% | 984 |
|
|
2015
Q1 | $449K | Buy |
5,052
+467
| +10% | +$47.4K | 0.02% | 967 |
|
|
2014
Q4 | $407K | Buy |
4,585
+277
| +6% | +$26.2K | 0.02% | 948 |
|
|
2014
Q3 | $418K | Buy |
4,308
+1,533
| +55% | +$149K | 0.02% | 804 |
|
|
2014
Q2 | $255K | Buy |
+2,775
| New | +$211K | 0.01% | 1308 |
|
Other funds holding PCRX
DPCM
VPM
VCM
